Related Experiment Video
Updated: Feb 17, 2026

04:06
Author Spotlight: Minimally Invasive Relief for Occipital Neuralgia at the Nuchal Line
Published on: September 13, 2024
3.4K
When a Withdrawal Aid Mimics a Brainstem Lesion: Gabapentin-associated Transient Ophthalmoplegia
Journal of Addiction Medicine
|February 16, 2026
Summary
Gabapentin can cause reversible neurological side effects like double vision during alcohol withdrawal treatment. Discontinuation of the medication leads to rapid symptom resolution, highlighting the need for careful monitoring.
Area of Science:
- Neurology
- Pharmacology
- Addiction Medicine
Background:
- Gabapentin is a common benzodiazepine-sparing agent for alcohol withdrawal.
- Neurological adverse effects are known but ocular motor abnormalities are rarely reported.
- Early recognition is crucial for patient management.
Purpose of the Study:
- To report a case of gabapentin-induced ocular motor abnormalities during alcohol withdrawal.
- To emphasize the importance of considering medication side effects in alcohol withdrawal management.
Main Methods:
- A case report of a 60-year-old male treated for alcohol use disorder.
- Gabapentin initiated for mild alcohol withdrawal; developed diplopia and ophthalmoplegia within 24 hours.
- Symptoms resolved rapidly after gabapentin discontinuation; neuroimaging and labs were normal.
Main Results:
- A clear temporal link between gabapentin initiation and neurological symptoms (diplopia, nystagmus, ataxia).
- Symptoms localized to cerebellar-brainstem pathways, consistent with gabapentin's mechanism.
- Medication-induced effect confirmed by rapid symptom resolution upon discontinuation.
Conclusions:
- Gabapentin is effective for mild-moderate alcohol withdrawal but rapid dose increases risk reversible neurological effects.
- New-onset diplopia or ocular motor issues warrant medication review and neurological assessment.
- This case underscores the need for vigilance regarding gabapentin's potential neurological adverse effects.
Related Concept Videos
Antiepileptic Drugs: Potassium Channel Activators
711
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
711
Antiepileptic Drugs: GABAergic Pathway Potentiators
1.4K
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
1.4K
Antiepileptic Drugs: Glutamate Antagonists
1.0K
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
1.0K
Glaucoma: Overview
1.4K
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
1.4K
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
944
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
944
Skeletal Muscle Relaxants: Adverse Effects
907
Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
Unlike...
907

